4//SEC Filing
Theagene Jean-Manasse 4
Accession 0001127602-23-019768
CIK 0001878313other
Filed
Jul 4, 8:00 PM ET
Accepted
Jul 5, 8:13 AM ET
Size
5.1 KB
Accession
0001127602-23-019768
Insider Transaction Report
Form 4
Theagene Jean-Manasse
Director
Transactions
- Award
Stock Options
2023-06-30+8,910→ 8,910 totalExercise: $2.20From: 2023-06-30Exp: 2033-06-30→ Common Stock (8,910 underlying)
Footnotes (1)
- [F1]The stock options, granted on June 30, 2023 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date.
Documents
Issuer
MAIA Biotechnology, Inc.
CIK 0001878313
Entity typeother
Related Parties
1- filerCIK 0001969857
Filing Metadata
- Form type
- 4
- Filed
- Jul 4, 8:00 PM ET
- Accepted
- Jul 5, 8:13 AM ET
- Size
- 5.1 KB